It is widely accepted that the EGFR pathway, as well as downstream networks involving MEK‐ERK and PI3K‐AKT, was hyperactivated and played important roles in promoting tumour metastasis of multiple cancers, including HCC.29, 37, 38. The gene discussed is EGFR; the disease is hepatocellular carcinoma.